Injective, a Layer 1 blockchain focused on decentralized trading and financial applications, announced plans to support native issuance of USD Coin (USDC) and integrate the Cross-Chain Transfer Protocol (CCTP) developed by USDC issuer Circle.

Key Details of the Integration

• Native USDC issuance: Users will be able to mint USDC directly on Injective rather than using bridged versions of the stablecoin.
• Cross-chain transfers: The CCTP allows USDC to move seamlessly between supported blockchains. It works by burning tokens on the source chain and minting an equivalent amount on the destination chain, reducing risks associated with traditional bridge-based transfers.
• DeFi and trading support: Injective supports decentralized markets, including spot trading, derivatives, and tokenized assets. USDC acts as a base asset in these markets, providing liquidity, collateral, and stability for trading positions and DeFi protocols.

USDC Growth and Market Context

• USDC’s supply is approaching $80 billion, up more than 42% year-over-year from about $55 billion a year ago.
• The total stablecoin market is currently valued at around $300 billion.
• Research from Mizuho indicates USDC now accounts for 64% of “adjusted” stablecoin transfer volume year-to-date, surpassing Tether (USDT) in that metric. Adjusted volume reflects transfers linked to real-world economic activity, such as payments, DeFi interactions, or exchange movements.
• Despite this growth, USDT remains the largest stablecoin globally with a market capitalization of roughly $184 billion.

Strategic Impact

The integration of CCTP and native USDC issuance strengthens Injective’s role as a multi-chain trading hub and enhances capital efficiency, security, and interoperability for users. It positions the blockchain to better serve DeFi protocols and decentralized markets that rely on stablecoins as core liquidity and collateral.